碘环己铵 | 7681-78-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 碘环己铵
• 英文名称: Mebezonium Iodide
• 英文别名: trimethyl-[4-[[4-(trimethylazaniumyl)cyclohexyl]methyl]cyclohexyl]azanium;diiodide
• CAS: 7681-78-9
• 化学式: C19H40I2N2
• 分子量: 550.3
• InChiKey: CWPAAKNARYMZLM-UHFFFAOYSA-L

物化性质

• 溶解度：
  甲醇（微溶）、水（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  -2.09
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
  申请人：Frick Wendelin

  公开号：US20050014704A1

  公开（公告）日：2005-01-20

  Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof. The invention relates to substituted aromatic fluoroglycoside derivatives of the formula I in which the radicals have the stated meanings, and their physiologically tolerated salts and process for their preparation. The compounds are suitable for example as antidiabetics.

  新型芳香族氟糖苷衍生物，包含这些化合物的药物，以及它们的用途。该发明涉及公式I的取代芳香族氟糖苷衍生物，其中基团具有所述含义，以及它们的生理耐受盐和制备过程。这些化合物例如适用于抗糖尿病药物。
• NOVEL FLUOROGLYCOSIDE DERIVATIVES OF PYRAZOLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF
  申请人：BRUMMERHOP Harm

  公开号：US20070197623A1

  公开（公告）日：2007-08-23

  The invention relates to substituted fluoroglycoside derivatives of pyrazoles of formula (I) as further defined in the specification, to the physiologically compatible salts thereof, to a method for their production, and to their use as antidiabetics.

  本发明涉及一种代替氟基的吡唑烷基糖苷衍生物，其化学式为（I），在规范中进一步定义，其生理兼容盐的制备方法，以及它们作为抗糖尿病药物的用途。
• Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
  申请人：Aventis Pharma Deutschland GmbH

  公开号：US20040259819A1

  公开（公告）日：2004-12-23

  Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof. The invention relates to substituted heterocyclic fluoroglycoside derivatives of the formula I 1 in which the radicals have the stated meanings, and their physiologically tolerated salts and processes for their preparation. The compounds are suitable for example as antidiabetics.

  新型杂环氟代糖苷衍生物、含有这些化合物的药物以及其使用方法。本发明涉及式I1的取代杂环氟代糖苷衍生物，其中基团具有所述含义，以及其生理上耐受的盐和制备它们的过程。这些化合物例如适用于抗糖尿病药物。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
  申请人：——

  公开号：US20040138143A1

  公开（公告）日：2004-07-15

  Novel thiophene glycoside derivatives of the formula I 1 in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and processes for their preparation are disclosed. The compounds are suitable, for example, as antidiabetics.

  本发明涉及一种公式I1的新型噻吩糖苷衍生物，其中基团具有所述的含义，以及其生理上可耐受的盐和制备它们的过程。该化合物适用于例如作为抗糖尿病药物。